Genomic Profiling Reveals Differences in Primary Central Nervous System Lymphoma and Large B-Cell Lymphoma, With Subtyping Suggesting Sensitivity to BTK Inhibition | Zendy

Eric A. Severson | Zendy; James Haberberger | Zendy; Amanda Hemmerich | Zendy; Richard S.P. Huang | Zendy; Claire Edgerly | Zendy; Kelsie Schiavone | Zendy; Adib Najafian | Zendy; Matthew Hiemenz | Zendy; Mirna Lechpammer | Zendy; JoAnne Vergilio | Zendy; Glenn J. Lesser | Zendy; Roy E. Strowd | Zendy; Julia A. Elvin | Zendy; Jeffrey S. Ross | Zendy; Priti S. Hegde | Zendy; Brian M. Alexander | Zendy; Samuel Singer | Zendy; Shakti Ramkissoon | Zendy

Open Access

Genomic Profiling Reveals Differences in Primary Central Nervous System Lymphoma and Large B-Cell Lymphoma, With Subtyping Suggesting Sensitivity to BTK Inhibition

Author(s) -

Eric A. Severson,

James Haberberger,

Amanda Hemmerich,

Richard S.P. Huang,

Claire Edgerly,

Kelsie Schiavone,

Adib Najafian,

Matthew Hiemenz,

Mirna Lechpammer,

JoAnne Vergilio,

Glenn J. Lesser,

Roy E. Strowd,

Julia A. Elvin,

Jeffrey S. Ross,

Priti S. Hegde,

Brian M. Alexander,

Samuel Singer,

Shakti Ramkissoon

Publication year - 2022

Publication title -

the oncologist

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.176

H-Index - 164

eISSN - 1549-490X

pISSN - 1083-7159

DOI - 10.1093/oncolo/oyac190

Subject(s) - diffuse large b cell lymphoma , lymphoma , medicine , cancer research , aggressive lymphoma , ibrutinib , bcl6 , comparative genomic hybridization , b cell , germinal center , oncology , rituximab , immunology , gene , biology , chronic lymphocytic leukemia , genetics , leukemia , genome , antibody

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research